{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:22:27Z","timestamp":1788398547157,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Obstructed total anomalous pulmonary venous connection (TAPVC) typically present with severe cardiovascular decompensation and requires urgent surgical management. Pulmonary arterial hypertension (PAH) is a major risk factor affecting mortality. Perioperative management focuses on providing inotropic support and managing potential pulmonary hypertensive episodes. Milrinone and inhaled nitric oxide (iNO) efficiently reduce pulmonary artery pressure (PAP) and help to improve the outcome. The aim was to determine the outcome of patients with high PAP with milrinone alone and a combination of iNO and milrinone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>After ethical committee approval, the study was conducted over a period of 3 years in 80 patients with obstructed TAPVC repair. A total of 80 patients having severe PAH (supra systemic arterial pressure) randomly divided into two groups with 40 patients in each (M &amp; MN). Group M (milrinone) patients received milrinone and Group MN (milrinone &amp; iNO) patients received both milrinone (after opening aortic cross clamp) and iNO (post operative ICU). Ventilation time, hospital stay, ICU stay, complications, in hospital mortality were compared between both groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>\n                      Ventilation time, Intensive Care Unit (ICU) stay, hospital stay for group M was 8.02 \u00b1 5.74 days, 11.25 \u00b1 7.33 day, 14.92 \u00b1 8.55 days, respectively, and for group MN was 5.02 \u00b1 1.78 days, 8.27 \u00b1 3.24 days, 10.3 \u00b1 3.18 days, respectively. In hospital mortality for group M and MN was 10% and 2.5%, respectively.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value for each variable was significant &lt; 0.05 (except mortality).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Most of the patients with obstructed TAPVC had severe PAH. Management of severe PAH with a combination of milrinone with iNO had a better outcome than milrinone alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_56_22","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T03:01:24Z","timestamp":1687230084000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Outcome of Obstructed Total Anamalous Pulmonary Venous Connection (TAPVC) Repair Patients with Milrinone Versus Milrinone and Inhaled Nitric Oxide (INO): A Prospective Randomized Observational Study"],"prefix":"10.4103","volume":"26","author":[{"given":"Srikanth","family":"Gujja","sequence":"first","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrugesh","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R","family":"Chuada","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemang","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kaul","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Research, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"R1-20240901","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1089253216672442","article-title":"Total anomalous pulmonary venous connection:Preoperative anatomy, physiology, imaging, and interventional management of postoperative pulmonary venous obstruction","volume":"21","author":"Files","year":"2017","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R2-20240901","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4250\/jcu.2014.22.4.213","article-title":"Total anomalous pulmonary venous return in siblings","volume":"22","author":"Kim","year":"2014","journal-title":"J Cardiovasc Ultrasound"},{"key":"R3-20240901","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1161\/CIRCULATIONAHA.110.940825","article-title":"Total anomalous pulmonary venous connection:morphology and outcome from an international population-based study","volume":"122","author":"Seale","year":"2010","journal-title":"Circulation"},{"key":"R4-20240901","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/tera.1420440408","article-title":"Total anomalous pulmonary venous return:Familial and environmental factors. The Baltimore-Washington infant study group","volume":"44","author":"Correa-Villasenor","year":"1991","journal-title":"Teratology"},{"key":"R5-20240901","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpeds.2008.05.059","article-title":"Prevalence of congenital heart defects in metropolitan Atlanta, 1998\u20132005","volume":"153","author":"Reller","year":"2008","journal-title":"J Pediatr"},{"key":"R6-20240901","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pedneo.2012.04.002","article-title":"Total anomalous pulmonary venous connection:15 years'experience of a tertiary care center in Taiwan","volume":"53","author":"Fu","year":"2012","journal-title":"Pediatr Neonatol"},{"key":"R7-20240901","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajmg.1320400122","article-title":"Father and two children with total anomalous pulmonary venous connection","volume":"40","author":"Raisher","year":"1991","journal-title":"Am J Med Genet"},{"key":"R8-20240901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone:Four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"key":"R9-20240901","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J Crit Care"},{"key":"R10-20240901","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0003-4975(96)00542-5","article-title":"Rebound pulmonary hypertension after inhalation of nitric oxide","volume":"62","author":"Atz","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R11-20240901","first-page":"308","article-title":"Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease","volume":"24","author":"Kovalchin","year":"1997","journal-title":"Tex Heart Inst J"},{"key":"R12-20240901","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/hrt.39.1.80","article-title":"Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy","volume":"39","author":"Haworth","year":"1977","journal-title":"Br Heart J"},{"key":"R13-20240901","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1010-7940(96)80111-4","article-title":"Early and long-term results for correction of total anomalous pulmonary venous drainage (TAPVD) in neonates and infants","volume":"10","author":"Sinzobahamvya","year":"1996","journal-title":"Eur J Cardiothorac Surg"},{"key":"R14-20240901","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0146-0005(97)80009-2","article-title":"Inhaled nitric oxide in the neonate with cardiac disease","volume":"21","author":"Atz","year":"1997","journal-title":"Semin Perinatol"},{"key":"R15-20240901","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00595-004-2887-1","article-title":"Inhaled nitric oxide therapy after Fontan-type operations","volume":"35","author":"Yoshimura","year":"2005","journal-title":"Surg Today"},{"key":"R16-20240901","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-5223(97)70355-6","article-title":"Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis","volume":"113","author":"Gamillscheg","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-20240901","first-page":"H1849","article-title":"Inhaled nitric oxide inhibits NOS activity in lambs:Potential mechanism for rebound pulmonary hypertension","volume":"277","author":"Black","year":"1999","journal-title":"Am J Physiol"},{"key":"R18-20240901","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","article-title":"Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension","volume":"28","author":"Deb","year":"2000","journal-title":"Critic Care Med"},{"key":"R19-20240901","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.PCC.0000124021.25393.2D","article-title":"Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs","volume":"5","author":"Thelitz","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"R20-20240901","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.athoracsur.2008.05.014","article-title":"Nitric oxide and milrinone:Combined effect on pulmonary circulation after Fontan-type procedure:A prospective, randomized study","volume":"86","author":"Cai","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R21-20240901","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.pa.25.040185.001131","article-title":"The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation","volume":"25","author":"Ignarro","year":"1985","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R22-20240901","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.52.12.1051","article-title":"Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension","volume":"52","author":"Kharitonov","year":"1997","journal-title":"Thorax"},{"key":"R23-20240901","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/0003-4975(95)00812-8","article-title":"Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension","volume":"60","author":"Curran","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R24-20240901","first-page":"9","article-title":"Inhaled nitric oxide as a therapeutic modality:Is it good or bad?","volume":"3","author":"Stamler","year":"1995","journal-title":"New Horiz"},{"key":"R25-20240901","first-page":"93","article-title":"Nitric oxide is an antiadhesive molecule for leukocytes","volume":"3","author":"Kanwar","year":"1995","journal-title":"New Horiz"},{"key":"R26-20240901","first-page":"73","article-title":"Inhaled nitric oxide in acute lung disease","volume":"3","author":"Cioffi","year":"1995","journal-title":"New Horiz"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_56_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:13:44Z","timestamp":1787760824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_56_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_56_22","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-03-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}